Captor Therapeutics ® Investor Relations

      Investor Relations

      Announcement of the Central Securities Depository of Poland on the conditional registration of series K ordinary bearer shares

      Publication date: 2022-06-28
      Number: RB ESPI 23/2022

      Current Report No. 23/2022

      Date of preparation: 28 June 2022

      Subject: Announcement of the  Central Securities Depository of Poland on the conditional registration of series K ordinary bearer shares

      Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company"), informed about the statement of the  Central Securities Depository of Poland ("KDPW") No. 568/2022 on the conclusion, at the request of the Company, of an agreement for the registration in the depository of securities of 30,738 ordinary series K bearer shares with a nominal value of PLN 0.10 each and ISIN code PLCPTRT00014.

      The registration of the shares is conditional and will take place within 3 days of receipt by the Central Securities Depository of Poland of a decision to introduce the above-mentioned shares to trading on the regulated market to which other shares of the Company bearing the above-mentioned ISIN code have been introduced, but not earlier than on the date indicated in that decision as the date of introduction of those shares to trading on that regulated market.

       

      Detailed legal basis:

      §17(1)(1) of the RMF on current and periodic information provided by issuers of securities and conditions for recognizing as equivalent information required by the laws of a non-member state